Home

News

The head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be subject to scrutiny following a new report showing a much larger share of women experience adverse effects after taking it than previously believed.

Sen. Josh Hawley, R-Mo., shared the contents of a letter he received from Food and Drug Administration Commissioner Marty Makary in an X post Monday. Makary’s letter came in response to a letter Hawley had sent Makary on April 28 expressing concern about his insistence that he had “no plans to take action” on mifepristone, referring to the abortion pill.

Read: 7 reactions to the death of 'father of the abortion pill'

Get Our Latest News for FREE Subscribe to get daily/weekly email with the top stories (

See Full Page